The Company

At CancerIQ, our technology is expanding access to precision cancer prevention, early detection & treatment to more patient populations. We build software and design services that make it easy for health systems to use genetic information to get ahead of cancer at scale. Our best-in-class, science-based platform is proven to double genetic counseling service capacity, quadruple genetic testing uptake & significantly improve screening compliance. To date, CancerIQ has raised over $26 million to deliver on our mission, with our Series B funding round led by Merck Global Health Innovation Fund and Amgen Ventures.

Our team is made up of a committed, all-in group of people who are as driven to ending cancer as we know it as the providers and patients we serve. This has led to a growing network of over 200 clinical locations across the country, with a robust ecosystem of partners in the diagnostic and genomics space behind us. But we’re committed to scaling quickly – in this era of tremendous progress against cancer, we’re looking for people to be just as tremendously committed to their work at CancerIQ. If you want your work to matter, join us.

The Role

This individual will be responsible for optimizing utilization of Cancer IQ within medical practices and health systems with a focus on the following specialties: Genetics, Oncology, Surgery, Gastroenterology, Breast Imaging and Preventive Care (OB/GYN, Primary Care, Internal Medicine) via programmatic design, protocol development/quality improvement via Lean methodology, and project management.

Ensure customers are utilizing Cancer IQ services to their contracted level while partnering with Business Development to find growth opportunities.

· Collaboration with Account Executives, Executive Sponsors and Product Specialists to target, plan and drive Cancer IQ utilization within health care practices or facilities at the clinical and operational levels, to achieve improved patient outcomes.

· Providing Quality Improvement expertise that includes analysis and solutions to make cancer risk assessment via Cancer IQ standard of care with healthcare providers. Including but not limited to Lean and Six Sigma methodology to drive consistent, reliable and dependable processes to support physician behavior and impact patient outcomes.

· Analysis, understanding and demonstration of revenue generation resulting from practice population-based risk stratification, including cost effectiveness associated with proper utilization of personalized molecular diagnostics. This requires a basic understanding of billing, reimbursement and the impact of healthcare reform on physician’s practices in addition to how healthcare quality and delivery is measured and rewarded.

· Building relationships between different disciplines across the academic and community network of healthcare providers to optimize an integrated multidisciplinary approach to the identification, diagnosis and management of high-risk patients.